PFKFB3-mediated glycometabolism reprogramming modulates endothelial differentiation and angiogenic capacity of placenta-derived mesenchymal stem cells

Yang Zhang,Yanqi Zhong,Weifang Liu,Fanghui Zheng,Yin Zhao,Li Zou,Xiaoxia Liu
DOI: https://doi.org/10.1186/s13287-022-03089-3
2022-08-03
Abstract:Mesenchymal stem cells (MSCs) have a great potential ability for endothelial differentiation, contributing to an effective means of therapeutic angiogenesis. Placenta-derived mesenchymal stem cells (PMSCs) have gradually attracted attention, while the endothelial differentiation has not been fully evaluated in PMSCs. Metabolism homeostasis plays an important role in stem cell differentiation, but less is known about the glycometabolic reprogramming during the PMSCs endothelial differentiation. Hence, it is critical to investigate the potential role of glycometabolism reprogramming in mediating PMSCs endothelial differentiation.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?